AstraZeneca Says Enhertu Application for HER2-Positive Solid Tumors Slated for FDA Priority Review
AstraZeneca Says Enhertu Application for HER2-Positive Solid Tumors Slated for FDA Priority Review
阿斯利康表示，Enhertu的HER2阳性实体瘤申请将接受美国食品药品管理局的优先审查
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册